Curriculum Vitae

DATO' PROF. DR. ADEEBA BINTI KAMARULZAMAN

Honorary Professor
  • Department of Medicine
    Faculty of Medicine
  • adeeba
  • +603-79492050

BIOGRAPHY

Professor Adeeba Kamarulzaman graduated from Monash University in 1987 and trained in internal medicine and infectious diseases at the Monash Medical Centre and Fairfield Infectious Diseases Hospital, Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and an Adjunct Associate Professor at Yale University, USA. She established the Centre of Excellence for Research on AIDS (CERiA) that conducts multi-disciplinary research on HIV ranging from clinical to public health and policy research.

Professor Kamarulzaman has used her clinical and academic leadership to engage in the national and community response to HIV/AIDS. She is currently Chairman of the Malaysian AIDS Foundation and an Executive Council member of the Malaysian AIDS Council, the peak HIV NGO in Malaysia.

At the international level, Professor Kamarulzaman is presently an Executive Council Member of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV. She has also been an advisor to numerous WHO committees on HIV/AIDS. She has played a key role in the establishment and ongoing activities and collaborations of a regional HIV research network initiative; TREAT Asia.

Her achievements have been recognised through several national and international awards including the Tun Mahathir Science and the Merdeka Awards for her role as a member of the University of Malaya’s Nipah Investigative Team. She is the first recipient of the Advance Australia Global Award in the category of Alumni in 2012 and in April 2015 she was honoured with a Doctor of Laws (honoris causa) from her alma mater, Monash University. She also has the distinct honour of having been featured in both The Lancet and Science publications in 2013 and 2014 respectively.

 

AREAS OF EXPERTISE

  • INFECTIOUS/COMMUNICABLE DISEASES
    Specialist In Infectious Diseases NSR
  • INFECTIOUS/COMMUNICABLE DISEASES

ACADEMIC QUALIFICATION

  • FRACP(1995) (AUS), (Internal Medicine)
    Royal Australiasian College of Physicians
  • MBBS, (PERUBATAN DAN PEMBEDAHAN)
    Monash University, Australia

ADMINISTRATIVE DUTIES

  • Ahli Lembaga Penasihat CIC
    09 Feb 2015 - present (University Malaya)
  • Ahli Lembaga Pengurus Pusat Perubatan University Malaya
    20 Apr 2015 - present (University Malaya)
  • Senate member, University Malaya
    01 Aug 2010 - 24 Jan 2022 (University Malaya)
  • Head of Unit
    01 Jan 2020 - 31 Dec 2021 (Centre of Excellence for Research in Aids (Ceria), Faculty of Medicine)
  • Dean
    03 Dec 2018 - 02 Dec 2020 (Dean's Office, Faculty of Medicine)
  • AHLI MAJLIS PENASIHAT KESIHATAN
    09 Nov 2018 - 08 Nov 2020 (University Malaya)
  • Head of Unit
    01 Jan 2018 - 31 Dec 2019 (Centre of Excellence for Research in Aids (Ceria), Faculty of Medicine)
  • Dean
    11 Oct 2018 - 02 Dec 2018 (Dean's Office, Faculty of Medicine)
  • Exercising The Function of Dean
    01 Jul 2018 - 10 Oct 2018 (Dean's Office, Faculty of Medicine)
  • Dean
    01 Jul 2016 - 30 Jun 2018 (Dean's Office, Faculty of Medicine)
  • Head of Unit
    01 Jan 2016 - 31 Dec 2017 (Centre of Excellence for Research in Aids (Ceria), Deputy Vice-Chancellor (Research and Innovation))
  • Dean
    01 Jul 2014 - 30 Jun 2016 (Dean's Office, Faculty of Medicine)
  • Head of Unit
    01 Jan 2015 - 31 Dec 2015 (Centre of Excellence for Research in Aids (Ceria), Deputy Vice-Chancellor (Research and Innovation))
  • Head of Unit
    02 Jan 2014 - 31 Dec 2014 (Centre of Excellence for Research in Aids (Ceria), Deputy Vice-Chancellor (Research and Innovation))
  • Dean
    01 Jul 2012 - 30 Jun 2014 (Dean's Office, Faculty of Medicine)
  • Dean
    01 Jul 2011 - 30 Jun 2012 (Dean's Office, Faculty of Medicine)
  • Chair - Infection Control Committee , UMMC
    01 Jan 2006 - 31 Dec 2011 (University Malaya)

MEMBERSHIPS

  • ACADEMY OF SCIENCE MALAYSIA , ACTIVE MEMBER
    Since 2016 (National)
  • ACADEMY OF MEDICINE, ACADEMIC COMMITTEE MEMBER
    Since 2015 (National)
  • MALAYSIAN MEDICAL ASSOCIATION , ACTIVE MEMBER
    Since 2014 (National)
  • AHLI JAWATANKUASA PENGAJIAN PROGRAM DOKTOR PERUBATAN, FAKULTI PERUBATAN DAN SAINS KESIHATAN, COMMITTEE MEMBER
    2018 to 2021 (National)
  • WORLD HEALTH ORGANIZATION, EXPERT PANEL MEMBER
    2017 to 2021 (International)
  • INTERNATIONAL AIDS SOCIETY , 1ST VICE PRESIDENT
    2018 to 2020 (International)
  • MERDEKA AWARD SECRETARIAT, COMMITTEE
    2018 to 2020 (National)
  • ACADEMY OF MEDICINE MALAYSIA, OTHERS
    2017 to 2018 (National)
  • MAJLIS PERUBATAN MALAYSIA, PANEL MEMBER
    2017 to 2017 (National)

AWARD AND STEWARDSHIP

  • Penghargaan Khas
    UMMC, 2021 (University)
  • SIJIL PENGHARGAAN KEPADA PANEL PAKAR PENASIHAT PIHAK BERKUASA KAWALAN DADAH
    PIHAK BERKUASA KAWALAN DADAH, KKM, 2019 (National)
  • President-Elect
    International AIDS Society, 2018 (International)
  • Certificate of Appreciation
    Perdana University, 2018 (National)
  • University Malaya
    University Malaya, 2017 (University)
  • DEGREE AWARDS
    SULTAN PERAK, 2016 (State)
  • Honarary Doctorates
    Monash University, 2015 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2014 (University)
  • Top Research Scientists Malaysia
    Akademi Sains Malaysia, 2014 (National)
  • Certificate of Credentialing & Privileging
    University Malaya, 2013 (University)
  • UM EXCELLENCE AWARD
    NAIB CANSELOR, 2012 (University)
  • Sijil Penghargaan - Jawatankuasa Majlis Penilaian Teknologi Kesihatan Dan Panduan Amalan Klinikal
    Kementerian Kesihatan Malaysia, 2012 (National)
  • Anugerah Cermerlang Universiti Malaya 2012
    University Malaya, 2012 (University)
  • Australian Education Achievement Award 2012 ( Winner - Alumni Category )
    Australian High Commissioner, Kuala Lumpur, 2012 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2011 (University)
  • Finalis Anugerah Perdana Menteri Penggiat Sosial Wanita 2011
    Menteri Pembangunan Wanita, Keluarga dan Masyarakat, 2011 (National)
  • 50 Emerging Women Leader in Asia Pacific 2011 Advance Australia
    Australian Government, 2011 (International)
  • Pingat Bakti Setia Jabatan Penjara Malaysia
    Jabatan Penjara Malaysia, 2009 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2008 (University)
  • Merdeka Award
    Exxon Mobil, Petronas and Shell, 2008 (National)
  • Tun Mahathir Science Award
    Malaysian Academy of Science, 2008 (National)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2007 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2006 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2005 (University)
  • Swarovski Life Ball Crystal of Hope Award
    Austrian Life Ball, 2005 (International)
  • Australian-Asian Fellowship Award
    Australian Government, 2002 (International)
  • International AIDS Fellowship Programme
    International Society of Infectious Diseases, 1999 (International)
  • Fellow in Infectious Diseases
    Senior Medical Staff, Fairfield Hospital, 1995 (International)

PUBLICATIONS

Article in Journal
  1. Archana Krishnan 1, Damian Weikum 2, Claire Cravero 3, Adeeba Kamarulzaman 4, Frederick L Altice 2 4 5. Assessing mobile technology use and mHealth acceptance among HIV-positive men who have sex with men and transgender women in Malaysia
  2. Balasingam Vicknasingam 1, Nur Afiqah Mohd Salleh 2 3, Weng-Tink Chooi 4, Darshan Singh 1, Norzarina Mohd Zaharim 4, Adeeba Kamarulzaman 3 5, Marek C Chawarski 6. COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia
  3. Commissioners of and collaborators with the International AIDS Society Lancet Commission on Health and Human Rights. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights
  4. Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution Kim Tien Ng, Yutaka Takebe, Adeeba Kamarulzaman & Kok Keng Tee
  5. Kim Sui Wan 1 2, Peter Seah Keng Tok 1 2, Kishwen Kanna Yoga Ratnam 1 2, Nuraini Aziz 1 2, Marzuki Isahak 1, Rafdzah Ahmad Zaki 1, Nik Daliana Nik Farid 1, Noran Naqiah Hairi 1, Sanjay Rampal 1, Chiu-Wan Ng 1, Mohd Fauzy Samsudin 1 2, Vinura Venugopal 1 2, Mohammad Asyraf 1 2, Narisa Hatun Damanhuri 1 2, Sanpagavalli Doraimuthu 1 2, Catherine Thamarai Arumugam 1 2, Thaneswaran Marthammuthu 1 2, Fathhullah Azmie Nawawi 1 2, Faiz Baharudin 1 3, Diane Woei Quan Chong 1 2, Vivek Jason Jayaraj 1 2, Venna Magarita 3, Sasheela Ponnampalavanar 3 4, Nazirah Hasnan 3 5, Adeeba Kamarulzaman 3 4, Mas Ayu Said 1. Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country
  6. Melinda Wang 1, Sin How Lim 2 3, Britton A Gibson 4, Iskandar Azwa 5, Thomas E Guadamuz 6, Frederick L Altice 1 2 7, Adeeba Kamarulzaman 1 2, Jeffrey A Wickersham 1 2. Correlates of newly diagnosed HIV infection among cisgender women sex workers and transgender women sex workers in Greater Kuala Lumpur, Malaysia
  7. Rebecca T Henry 1, Awachana Jiamsakul 1, Matthew Law 1, Marcelo Losso 2, Adeeba Kamarulzaman 3, Praphan Phanuphak 4, Nagalingeswaran Kumarasamy 5, Sharne Foulkes 6, Lerato Mohapi 7, Chidi Nwizu 8, Robin Wood 9, Anthony Kelleher 1, Mark Polizzotto 1, SECOND-LINE Study Group . Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants
  8. Sean Tackett 1, Jeremy Sugarman 2 3, Chirk Jenn Ng 4, Adeeba Kamarulzaman 5, Joseph Ali 2. Developing a competency framework for health research ethics education and training
  9. Stefan Baral, Amrita Rao, Jean Olivier Twahirwa Rwema, Carrie Lyons, Muge Cevik, Anna E K gesten, Daouda Diouf, Annette H Sohn, Refilwe Phaswana-Mafuya, Adeeba Kamarulzaman, Gregorio Millett, Julia L Marcus, Sharmistha Mishra . Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review
  10. Stefan David Baral # 1, Katherine Blair Rucinski # 1, Jean Olivier Twahirwa Rwema # 1, Amrita Rao # 1, Neia Prata Menezes # 1, Daouda Diouf # 2, Adeeba Kamarulzaman # 3, Nancy Phaswana-Mafuya # 4, Sharmistha Mishra # 5. The Relationship Between the Global Burden of Influenza From 2017 to 2019 and COVID-19: Descriptive Epidemiological Assessment
  11. Susan C S Chong 1, Adeeba Kamarulzaman 2, Iskandar Azwa 3, Rong-Xiang Ng 3, Meng-Li Chong 4, Nishaan Raman 3, Adam Bourne 5. Delayed HIV testing and treatment seeking, and associated support needs among people living with HIV in Malaysia: a qualitative study
  12. Teri Roberts 1, Suvanand Sahu 2, James Malar 2, Timur Abdullaev 3, Wim Vandevelde 4, Yogan G Pillay 5, Paula I Fujiwara 6, Alasdair Reid 7, Shannon Hader 7, Satvinder Singh 8, Adeeba Kamarulzaman 1 9, Sevim Ahmedov 10. Turning threats into opportunities: how to implement and advance quality TB services for people with HIV during the COVID-19 pandemic and beyond
  13. Abdul W Ansari 1 2 3, Fareed Ahmad 4 5 6, Esaki M Shankar 2 7, Yean K Yong 8, Hong Y Tan 9, Roland Jacobs 4, Marie Larsson 10, Vijayakumar Velu 11, Adeeba Kamarulzaman 1 2, Reinhold E Schmidt 4. Brief Report: Diminished Coinhibitory Molecule 2B4 Expression Is Associated With Preserved iNKT Cell Phenotype in HIV Long-Term Nonprogressors
  14. Annette H Sohn 1, Nittaya Phanuphak 2, Stefan Baral 3, Adeeba Kamarulzaman 4. Know your epidemic, know your response: understanding and responding to the heterogeneity of the COVID-19 epidemics across Southeast Asia
  15. Chong DWQ, Jayaraj VJ, Rampal S, Said MA, Nik Farid ND, Ahmad Zaki R, Hairi NN, Hoe VCW, Isahak M, Ponnampalavanar S, Syed Omar SF, Sam IC, Hasnan N, Ong HC, Kamarulzaman A, Ng CW. Establishment of a hospital-based health care workers surveillance programme to keep them safe during the COVID-19 pandemic. Journal of Global Health 2020; 10: 1-3. doi: 10.7189/jogh.10.0203100
  16. Chong YM, Sam IC, Chong J, Kahar Bador M, Ponnampalavanar S, Syed Omar SF, Kamarulzaman A, Munusamy V, Wong CK, Jamaluddin FH, Chan YF. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia. PLoS Neglected Tropical Diseases 2020; 14: e0008744. doi: 10.1371/journal.pntd.0008744
  17. D Rupasinghe 1, S Kiertiburanakul 2, A Kamarulzaman 3, F Zhang 4, N Kumarasamy 5, R Chaiwarith 6, T P Merati 7, C D Do 8, S Khusuwan 9, A Avihingsanon 10, M P Lee 11, P S Ly 12, E Yunihastuti 13, K V Nguyen 14, R Ditangco 15, Y J Chan 16, S Pujari 17, O T Ng 18, J Y Choi 19, Blh Sim 20, J Tanuma 21, S Sangle 22, J Ross 23, M Law 1. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific
  18. Giovanni Guaraldi 1, Jovana Milic 1 2, Esteban Martinez 3, Adeeba Kamarulzaman 4, Cristina Mussini 1, Laura Waters 5, Anton Pozniak 6, Patrick Mallon 7, J rgen Rockstroh 8, Jeffrey V Lazarus 9. HIV care models during the COVID-19 era
  19. Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey Joris Hemelaar 1, Ramyiadarsini Elangovan 2, Jason Yun 2, Leslie Dickson-Tetteh 2, Shona Kirtley 3, Eleanor Gouws-Williams 4, Peter D Ghys 5, WHO-UNAIDS Network for HIV Isolation and Characterisation
  20. James H McMahon 1, Jennifer F Hoy 2, Adeeba Kamarulzaman 3, Linda-Gail Bekker 4, Chris Beyrer 5, Sharon R Lewin 6 .Leveraging the advances in HIV for COVID-19
  21. Meng Li, C., Jie Ying, F., Raj, D., Pui Li, W., Kukreja, A., Omar, S. F., Kamarulzaman, A., & Rajasuriar, R. (2020). A retrospective analysis of the care cascades for non-communicable disease and mental health among people living with HIV at a tertiary-care centre in Malaysia: opportunities to identify gaps and optimize care. Journal of the International AIDS Society, 23(11), e25638. https://doi.org/10.1002/jia2.25638
  22. Mohd Sani, N., Aziz, Z. & Kamarulzaman, A. Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects. Therapeutic Innovation & Regulatory Science (2020).10.1007/s43441-020-00243-y
  23. Rema Panickar 1 2, Wee Kee Wo 1, Norleen M Ali 1, Min Moon Tang 3, G R Letchuman Ramanathan 4, Adeeba Kamarulzaman 2, Zoriah Aziz 2 5. Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia
  24. Repurposing Antimalarials to Tackle the COVID-19 Pandemic Sanjeev Krishna,1,6, Yolanda Augustin,1 Jigang Wang,2,3,4 Chengchao Xu,3 Henry M. Staines,1 Hans Platteeuw,5 Adeeba Kamarulzaman,7 Amadou Sall,8 and Peter Kremsner6,9
  25. Sophia Archuleta 1 2, Po Ying Chia 3 4 5, Yuan Wei 6, Sharifah F Syed-Omar 7, Jenny G Low 8 9, Helen M Oh 2 10, Dale Fisher 1 2, Sasheela S L Ponnampalavanar 7, Limin Wijaya 8, Adeeba Kamarulzaman 7, Lucy C S Lum 7, Paul A Tambyah 1 2, Yee-Sin Leo 2 3 4 5 11, David C Lye 2 3 4 5 . Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study
  26. Ahn MY, Jiamsakul A, Khusuwan S, Khol V, Pham TT, Chaiwarith R, Avihingsanon A, Kumarasamy N, Wong WW, Kiertiburanakul S, Pujari S, Nguyen KV, Lee MP, Kamarulzaman A, Zhang F, Ditangco R, Merati TP, Yunihastuti E, Ng OT, Sim BLH, Tanuma J, Ratanasuwan W, Ross J, Choi JY; IeDEA Asia-Pacific. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019 Feb;22(2):e25228.
  27. Archuleta S, Chia PY, Wei Y, Syed-Omar SF, Low JG, Oh HM, Fisher D, Ponnampalavanar SSL, Wijaya L, Kamarulzaman A, Lum LCS, Tambyah PA, Leo YS, Lye DC. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study. Clin Infect Dis. 2019 Oct 18.
  28. Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, Wong WW, Avihingsanon A, Sun LP, Yunihastuti E, Pujari S, Do CD, Merati TP, Kantipong P, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Ng OT, Sim B, Ross J, Kiertiburanakul S; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8. PubMed PMID: 30620108; PubMed Central PMCID: PMC6422532.
  29. Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, Wong WW, Kamarulzaman A, Kantipong P, Avihingsanon A, Nguyen KV, Tanuma J, Ng OT, Sim BL, Merati TP, Choi JY, Ditangco R, Yunihastuti E, Sun LP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD). Antivir Ther. 2019;24(4):271-279.
  30. Chandra DK, Bazazi AR, Nahaboo Solim MA, Kamarulzaman A, Altice FL, Culbert GJ. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia. HIV Res Clin Pract. 2019 Feb;20(1):12-23.
  31. Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim BL, Sun LP, Van Nguyen K, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A; IeDEA Asia-Pacific. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region. J Int AIDS Soc. 2019 Jan;22(1):.
  32. Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD; WHO UNAIDS Network for HIV Isolation Characterisation. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019 Feb;19(2):143-155.
  33. Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP, Ly PS, Yunihastuti E, Kumarasamy N, Kamarulzaman A, Tanuma J, Zhang F, Choi JY, Kantipong P, Sim B, Ross J, Law M, Merati TP; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2019 Aug;20(7):439-449.
  34. Jiamsakul A, Polizzotto M, Wen-Wei Ku S, Tanuma J, Hui E, Chaiwarith R, Kiertiburanakul S, Avihingasanon A, Yunihastuti E, Kumarasamy N, Ly PS, Pujari S, Ditangco R, Do CD, Merati TP, Kantipong P, Zhang F, Van Nguyen K, Kamarulzaman A, Choi JY, Sim BLH, Ng OT, Ross J, Wong W. Brief Report: Malignancies in Adults Living With HIV in Asia. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):301-307. doi: 10.1097/QAI.0000000000001918. PubMed PMID: 30531303; PubMed Central PMCID: PMC6375805.
  35. Kamarulzaman A, Verster A, Altice FL. Prisons: ignore them at our peril. Curr Opin HIV AIDS. 2019 Sep;14(5):415-422.
  36. Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc. 2019 Mar;22(3):e25264.
  37. Lall P, Saifi R, Baggio D, Schoenberger SF, Choo M, Gilbert L, West B, El-Bassel N, Kamarulzaman A. Risk Factors for a Positive Hepatitis C Status in Fishermen in Kuantan Malaysia. Asia Pac J Public Health. 2019 Apr;31(3):227-237.
  38. Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia. AIDS Educ Prev. 2019 Jun;31(3):193-205.
  39. Lim SH, Alias H, Kien JKW, Akbar M, Kamarulzaman A, Wong LP. A Qualitative Study of HIV "Test-and-Treat" Experience Among Men Who Have Sex With Men in Malaysia.AIDS Educ Prev. 2019 Jun;31(3):193-205. doi: 10.1521/aeap.2019.31.3.193.
  40. Pasayan MKU, S Mationg ML, Boettiger D, Lam W, Zhang F, Ku SW, Merati TP, Chaiwarith R, Cuong DD, Yunihastuti E, Kiertiburanakul S, Van Kinh N, Avihingsanon A, Sun LP, Kamarulzaman A, Kantipong P, Kumarasamy N, Pujari S, Heng Sim BL, Ng OT, Choi JY, Tanuma J, Ross J, A Ditangco R. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):436-443. doi: 10.1097/QAI.0000000000001933. PubMed PMID: 30550488; PubMed Central PMCID: PMC6391185.
  41. Pham MD, Haile BA, Azwa I, Kamarulzaman A, Raman N, Saeidi A, Kahar Bador M, Tan M, Zhu J, Feng Y, Elliott JH, Garcia ML, Li F, Crowe SM, Luchters S, Anderson DA. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study. J Clin Microbiol. 2019
  42. Shrestha R, Lim SH, Altice FL, Copenhaver M, Wickersham JA, Saifi R, Ab Halim MA, Naning H, Kamarulzaman A. Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks. J Community Health. 2019 Aug 2.
  43. Tee YC, Earnshaw VA, Altice FL, Jin H, Kamarulzaman A, Wickersham JA. Evaluating Physicians' Intention to Discriminate Against Patients Living with HIV in Malaysia. AIDS Behav. 2019 Apr;23(4):1039-1047.
  44. Abdul Aziz SA, Mcstea M, Ahmad Bashah NS, Chong ML, Ponnampalavanar S, Syed Omar SF, Sulaiman H, Azwa I, Tan MP, Kamarulzaman A, Rajasuriar R, Kamaruzzaman SB. Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment. AIDS. 2018 May 15;32(8):1025-1034.
  45. Azzeri A, Shabaruddin FH, , Tan SS, Dahlui M, McDonald SA, Kamarulzaman A, Mohamed R. CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION AT INITIAL PRESENTATION TO TERTIARY CARE IN AN ASIAN MIDDLE-INCOME COUNTRY
  46. Barr -Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P. Expert consensus statement on the science of HIV in the context of criminal law. J Int AIDS Soc. 2018 Jul;21(7):e25161.
  47. Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018 Jul 28;392(10144):312-358.
  48. Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216.
  49. Khan F, Krishnan A, Ghani MA, Wickersham JA, Fu JJ, Lim SH, Dhaliwal SK, Kamarulzaman A, Altice FL. Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia. Subst Use Misuse. 2018 Jan 28;53(2):249-259.
  50. Lim SH, Akbar M, Wickersham JA, Kamarulzaman A, Altice FL. The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Int J Drug Policy. 2018 May;55:256-262.
  51. Lim SH, Brown SE, Shaw SA, Kamarulzaman A, Altice FL, Beyrer C. "You Have to Keep Yourself Hidden": Perspectives From Malaysian Malay-Muslim Men Who Have Sex With Men on Policy, Network, Community, and Individual Influences on HIV Risk. J Homosex. 2018 Oct 11:1-23.
  52. McDonald SA, Azzeri A, Shabaruddin FH, Dahlui M, Tan SS, Kamarulzaman A, Mohamed R. Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040. Appl Health Econ Health Policy. 2018 Aug 25. doi: 10.1007/s40258-018-0425-3.
  53. Mohd Salleh NA, Richardson L, Kerr T, Shoveller J, Montaner J, Kamarulzaman A, Milloy MJ. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. J Addict Med. 2018 Jul/Aug;12(4):308-314.
  54. Mukherjee T, Sakthivel R, Fong HY, McStea M, Chong ML, Omar SF, Chin AV, Kamaruzzaman S, Kamarulzaman A, Rajasuriar R, Cysique LA. Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia. AIDS Behav. 2018 Oct;22(10):3226-3233.
  55. Naning H, Al-Darraji HAA, McDonald S, Ismail NA, Kamarulzaman A. Modelling the Impact of Different Tuberculosis Control Interventions on the Prevalence of Tuberculosis in an Overcrowded Prison. Asia Pac J Public Health. 2018 Apr;30(3):235-243.
  56. Ng KT, Oong XY, Lim SH, Chook JB, Takebe Y, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Viral Load and Sequence Analysis Reveal the Symptom Severity, Diversity, and Transmission Clusters of Rhinovirus Infections. Clin Infect Dis. 2018 Jul 2;67(2):261-268.
  57. Oong XY, Chook JB, Ng KT, Chow WZ, Chan KG, Hanafi NS, Pang YK, Chan YF, Kamarulzaman A, Tee KK. The role of human Metapneumovirus genetic diversity and nasopharyngeal viral load on symptom severity in adults. Virol J. 2018 May 23;15(1):91.
  58. Rutledge R, Morozova O, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia. LGBT Health. 2018 Nov/Dec;5(8):484-493. doi: . Epub 2018 Nov 27.
  59. Stacey A. Shaw, Olivia Cornwell, Sin How Lim, Rumana Saifi, Lik Teng Ung & Adeeba Kamarulzaman. Allah will decide my life and death : Religion and spirituality among populations at risk for HIV in Malaysia
  60. Vijay A, Earnshaw VA, Tee YC, Pillai V, White Hughto JM, Clark K, Kamarulzaman A, Altice FL, Wickersham JA. Factors Associated with Medical Doctors' Intentions to Discriminate Against Transgender Patients in Kuala Lumpur, Malaysia. LGBT Health. 2018 Jan;5(1):61-68.
  61. Yong YK, Saeidi A, Tan HY, Rosmawati M, Enstr m PF, Batran RA, Vasuki V, Chattopadhyay I, Murugesan A, Vignesh R, Kamarulzaman A, Rajarajeswaran J, Ansari AW, Vadivelu J, Ussher JE, Velu V, Larsson M, Shankar EM. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161(++)TCR iV 7.2(+) Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. Front Immunol. 2018 Mar 19;9:472.
  62. Ahmad F, Shankar EM, Yong YK, Tan HY Ahrenstorf G, Jacobs R, Larsson M, Schmidt RE, Kamarulzaman A, Ansari AW.Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression.
  63. Bazazi AR, Vijay A, Crawford FW, Heimer R, Kamarulzaman A, Altice FL. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. AIDS Care. 2018 Jan;30(1):59-64.
  64. Beyrer C, Kamarulzaman A. Ethnic cleansing in Myanmar: the Rohingya crisis and human rights. Lancet. 2017 Sep 30;390(10102):1570-1573.
  65. Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. .
  66. Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). J Int AIDS Soc. 2017 Dec;20(4).
  67. Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD). Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther. 2017 May 5;14:27.
  68. Lall P, Shaw SA, Saifi R, Sherman S, Azmi NN, Pillai V, El-Bassel N, Kamarulzaman A, Wickersham JA. Acceptability of a microfinance-based empowerment intervention for transgender and cisgender women sex workers in Greater Kuala Lumpur, Malaysia. J Int AIDS Soc. 2017 Aug 2;20(1):21723.
  69. Leng CY, Low HC, Chua LL, Chong ML, Sulaiman H, Azwa I, Roberts JM, Kamarulzaman A, Rajasuriar R, Woo YL.Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.
  70. Lim LM, McStea M, Chung WW, Nor Azmi N, Abdul Aziz SA, Alwi S, Kamarulzaman A, Kamaruzzaman SB,Chua SS, Rajasuriar R.Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia.
  71. Lye, D. C., Archuleta, S., Syed-Omar, S. F., Low, J. G., Oh, H. M., Wei, Y., ... & Ooi, E. E. (2017). Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. The Lancet, 389(10079), 1611-1618.
  72. Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Int J Drug Policy. 2017 Sep;47:144-152.
  73. Naidu, S., Ponnampalvanar, S., Kamaruzzaman, S. B., & Kamarulzaman, A. (2017). Prevalence of metabolic syndrome among people living with HIV in developing countries: a systematic review. AIDS patient care and STDs, 31(1), 1-13.
  74. Oong XY, Ng KT, Takebe Y, Ng LJ, Chan KG, Chook JB, Kamarulzaman A, Tee KK.Identification and evolutionary dynamics of two novel human coronavirus OC43 genotypes associated with acute respiratory infections: phylogenetic, spatiotemporal and transmission network analyses.
  75. Rajasuriar, R., Chong, M. L., Bashah, A., Nor, S., Abdul Aziz, S. A., Mcstea, M., ... & Sharifah, F. (2017). Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy. Aids, 31(10), 1393-1403.
  76. Sit, P. S., Teh, C. S., Idris, N., Sam, I. C., Syed Omar, S. F., Sulaiman, H., . . . Ponnampalavanar, S. (2017). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect Dis, 17(1), 274. doi:10.1186/s12879-017-2384-y
  77. Tee KK, Bon AH, Chow WZ, Ng KT, Chan KG, Kamarulzaman A, Busch MP, Takebe Y. Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia. Genome Announc. 2017 Jun 29;5(26). pii: e00459-17. doi: . PubMed PMID: 28663289; PubMed Central PMCID: PMC5638273.
  78. Wegman MP, Altice FL, Kaur S, Rajandaran V, Osornprasop S, Wilson D, Wilson DP, Kamarulzaman A.Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study.
  79. Wickersham JA, Gibson BA, Bazazi AR, Pillai V, Pedersen CJ, Meyer JP, El-Bassel N, Mayer KH, Kamarulzaman A, Altice FL. Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study. Sex Transm Dis. 2017 Nov;44(11):663-670.
  80. Yap SH, Abdullah NK, McStea M, Takayama K, Chong ML, Crisci E, Larsson M, Azwa I, Kamarulzaman A, Leong KH, Woo YL, Rajasuriar R. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution. PLoS One. 2017 Oct 9;12(10):e0186000. .
  81. . Brown SE, Wickersham JA, Pelletier AR, Marcus RM, Erenrich R, Kamarulzaman A, Altice FL.Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs.
  82. Al-Darraji HA, Altice FL, Kamarulzaman A.Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community.
  83. Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK. 2016. Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia. Virol J 2016; 13(1):33.
  84. Al-Khannaq MN, Ng KT, Oong XY, Pang YK, Takebe Y, Chook JB, Hanafi NS, Kamarulzaman A, Tee KK.Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.
  85. Al-Khannaq, M.N., Ng, K.T., Oong, X.Y., Pang, Y.K., Takebe, Y., Chook, J.B., Hanafi, N.S., Kamarulzaman, A. and Tee, K.K., 2016. Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.The American journal of tropical medicine and hygiene, pp.15-0810.
  86. Azanan MS, Abdullah NK, Chua LL, Lum SH, Abdul Ghafar SS, Kamarulzaman A, Kamaruzzaman S, Lewin SR, Woo YL, Ariffin H, Rajasuriar R.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus. .
  87. Beyrer C, Kamarulzaman A, McKee M; Lancet HIV in Prisoners Group.Prisoners, prisons, and HIV: time for reform.
  88. Bick J,Culbert G, Al-Darraji HA,Koh C, Pillai V, Kamarulzaman A, Altice F.Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.
  89. Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
  90. Chow WZ, Bon AH, Keating S, Anderios F, Halim HA, Takebe Y, Kamarulzaman A, Busch MP, Tee KK. Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries.
  91. Chow WZ, Chan YF, Oong XY, Ng LJ, Nor E SS, Ng KT, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Genetic diversity, seasonality and transmission network of human metapneumovirus: identification of a unique sub-lineage of the fusion and attachment genes. Sci Rep 2016; 6:27730.
  92. Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goul o J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mej a D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Z bransk T, Beyrer C.Public health and international drug policy.
  93. Culbert GJ, Pillai V, Bick J, Al-Darraji HA, Wickersham JA, Wegman MP, Bazazi AR, Ferro E, Copenhaver M, Kamarulzaman A, Altice FL.Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia.
  94. Do TC, Boettiger D, Law M, Pujari S, Zhang F, Chaiwarith R, Kiertiburanakul S, Lee MP, Ditangco R, Wong WW, Nguyen KV, Merati TP, Pham TT, Kamarulzaman A, Oka S, Yunihastuti E, Kumarasamy N, Kantipong P, Choi JY, Ng OT, Durier N, Ruxrungtham K.Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.
  95. Earnshaw VA, Jin H, Wickersham JA, Kamarulzaman A, John J, Lim SH, and Altice FL. 2016. Stigma Toward Men Who Have Sex with Men Among Future Healthcare Providers in Malaysia: Would More Interpersonal Contact Reduce Prejudice? AIDS and Behavior Jan;20(1):98-106.DOI 10.1007/s10461-015-1168-x
  96. Gender identity, healthcare access, and risk reduction among Malaysia's mak nyah community Britton A. Gibson, Shan-Estelle Brown, Ronnye Rutledge, Jeffrey A. Wickersham, Adeeba Kamarulzaman & Frederick L. Altice
  97. Jiamsakul A, Kerr SJ, Ng OT, Lee MP, Chaiwarith R, Yunihastuti E, Van Nguyen K, Pham TT, Kiertiburanakul S, Ditangco R, Saphonn V, Sim BL, Merati TP, Wong W, Kantipong P, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Oka S, Mustafa M, Ratanasuwan W, Petersen B, Law M, Kumarasamy N; TREAT Asia HIV Observational Database (TAHOD).Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.
  98. Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL.Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. .
  99. Krishnan A, Brown SE, Ghani MA, Khan F, Kamarulzaman A, Altice FL.Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach.
  100. Ku NS, Jiamsakul A, Ng OT, Yunihastuti E, Cuong do D, Lee MP, Sim BL, Phanuphak P, Wong WW, Kamarulzaman A, Zhang F, Pujari S, Chaiwarith R, Oka S, Mustafa M, Kumarasamy N, Van Nguyen K, Ditangco R, Kiertiburanakul S, Merati TP, Durier N, Choi JY; TREAT Asia HIV Observational Databases (TAHOD).Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy.
  101. Lall P, Saifi R, Kamarulzaman A.Tobacco Consumption Among HIV-Positive Respondents: Findings From the Third Round of the National Family Health Survey.
  102. Lam EP, Moore CL, Gotuzzo E, Nwizu C, Kamarulzaman A, Chetchotisakd P, van Wyk J, Teppler H, Kumarasamy N, Molina JM, Emery S, Cooper DA, Boyd MA.Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
  103. Lunze K, Idrisov B, Golichenko M, Kamarulzaman A.Mandatory addiction treatment for people who use drugs: global health and human rights analysis.
  104. Michalopoulos LM, Jiwatram-Negr n T, Choo MK, Kamarulzaman A, El-Bassel N.The association between psychosocial and structural-level stressors and HIV injection drug risk behavior among Malaysian fishermen: A cross-sectional study.
  105. Mukherjee T Wickersham JA, Desai MM, Pillai V, Kamarulzaman A, Altice FL.Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
  106. Nasarruddin AM, Saifi RA, Othman S, Kamarulzaman A.Opening up the HIV epidemic: a review of HIV seropositive status disclosure among people who inject drugs.
  107. Ng KT, Chook JB, Oong XY, Chan YF, Chan KG, Hanafi NS, Pang YK, Kamarulzaman A, Tee KK. Performance of a Taqman assay for improved detection and quantification of human rhinovirus viral load. Sci Rep 2016; 6:34855.
  108. Rahman F, Kamarulzaman A.Southeast Asia in focus: stemming the reawakening of prohibitionism.
  109. Tan HY, Yong YK, Shankar EM, Paukovics G, Elleg rd R, Larsson M, Kamarulzaman A, French MA, Crowe SM.Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
  110. Tanuma J, Jiamsakul A, Makane A, Avihingsanon A, Ng OT, Kiertiburanakul S, Chaiwarith R, Kumarasamy N, Nguyen KV, Pham TT, Lee MP, Ditangco R, Merati TP, Choi JY, Wong WW, Kamarulzaman A, Yunihastuti E, Sim BL, Ratanasuwan W, Kantipong P, Zhang F, Mustafa M, Saphonn V, Pujari S, Sohn AH; TREAT Asia HIV Observational Databases (TAHOD).Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
  111. Yong YK, Shankar EM, Solomon A, Spelman T, Fairley CK, Elliott JH, Hoy J, Cameron PU, Kamarulzaman A, Lewin SR.Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
  112. Yong YK, Shankar EM, Westhorpe CL, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR.Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
  113. Zelenev A, Long E, Bazazi AR, Kamarulzaman A, Altice FL.The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling. .
  114. Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, Lee MP, Sim BL, Oka S, Wong W, Kamarulzaman A, Kantipong P, Phanuphak P, Ng OT, Kiertiburanakul S, Zhang F, Pujari S, Ditangco R, Ratanasuwan W, Merati TP, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Databases (TAHOD). Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):e85-92
  115. Al-Darraji HA, Tan C, Kamarulzaman A, Altice FL. Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med. 2015 Jun;72(6):442-7.
  116. Alireza Saeidi1,2, Vicky L. Tien Tien3, Rami Al-Batran4 , Haider A. Al-Darraji2, Hong Y. Tan2,Yean K. Yong2,Sasheela Ponnampalavanar2, Muttiah Barathan1, Devi V. Rukumani1,Abdul W. Ansari2, Vijayakumar Velu5, Adeeba Kamarulzaman2, Marie Larsson6, EsakiM. Shankar1,2*
  117. Ansari AW, Ahmad F, Meyer-Olson D, Kamarulzaman A, Jacobs R, Schmidt RE. Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci. 2015 Aug;72(16):3037-49
  118. Barathan M, Mohamed R, Saeidi A, Vadivelu J, Chang LY, Gopal K, Ram MR, Ansari AW, Kamarulzaman A, Velu V, Larsson M, Shankar EM. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest. 2015 May;45(5):466-74.
  119. Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS Behav. 2015 Dec;19(12):2347-57.
  120. Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2015 Jul;26(7):675-81.
  121. Boettiger DC, Kerr S, Ditangco R, Chaiwarith R, Li PC, Merati TP, Pham TT, Kiertiburanakul S, Kumarasamy N, Vonthanak S, Lee CK, Van Kinh N, Pujari S, Wong WW, Kamarulzaman A, Zhang F, Yunihastuti E, Choi JY, Oka S, Ng OT, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Law M; TREAT Asia HIV Observational Database. Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther. 2015 Jun 12
  122. Chan KG, Ng KT, Chong TM, Pang YK, Kamarulzaman A, Yin WF, Tee KK. Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing. J Genomics. 2015 Jun 3;3:72-4
  123. Chan KG, Ng KT, Pang YK, Chong TM, Kamarulzaman A, Yin WF, Tee KK. Genome Anatomy of Streptococcus parasanguinis Strain C1A, Isolated from a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Reveals Unusual Genomic Features. Genome Announc. 2015 May 28;3(3)
  124. Cheong HT, Chow WZ, Takebe Y, Chook JB, Chan KG, Al- Darraji HA, Koh C, Kamarulzaman A, Tee KK. Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. PLoS One. 2015 Jul 21;10(7):e0133883.
  125. Choo MK, El-Bassel N, Adam PC, Gilbert L, Wu E, West BS, Bazazi AR, De Wit JB, Ismail R, Kamarulzaman A. Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS One. 2015 Aug 5;10(8):e0118422.
  126. Chow WZ, Lim SH, Ong LY, Yong YK, Takebe Y, Kamarulzaman A, Tee KK. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. PLoS One. 2015 Sep 3;10(9):e0137281.
  127. Culbert GJ, Waluyo A, Iriyanti M, Muchransyah AP, Kamarulzaman A, Altice FL. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015 Apr 1;149:71-9.
  128. Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance-Monitoring Study TASER-M. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals. J Med Virol. 2015 Jul 3.
  129. Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC; TREAT Asia HIV Observational Database. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS. 2015 May;29(5):229-31.Epub 2015 Mar 16
  130. Lim, M. K., Lai, P. S. M., Ponnampalavanar, S. S. L. S., Omar, S. F. S., Taib, N. A., Yusof, M. Y., ... & Kamarulzaman, A. (2015). Antibiotics in surgical wards: use or misuse? A newly industrialized country s perspective. The Journal of Infection in Developing Countries, 9(11), 1264-1271.
  131. Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co- morbidities among women who use drugs in Malaysia: Important targets for intervention. Addict Behav. 2015 Sep 25;53:31-39.
  132. Lum, L. C., Omar, S. F. S., Ponnampalavanar, S. S. L. S., Tan, L. H., Sekaran, S. D., & Kamarulzaman, A. (2015). Cohorting dengue patients improves the quality of care and clinical outcome. PLoS neglected tropical diseases, 9(6), e0003836.
  133. McDonald SA, Dahlui M, Mohamed R, Naning H, Shabaruddin FH, et al. (2015) Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia. PLoS ONE 10(6): e0128091. doi: 10.1371/journal.pone.0128091
  134. Ng KT, Oong XY, Pang YK, Hanafi NS, Kamarulzaman A, Tee KK. Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains. Emerging microbes & infections 2015;4(8), p.e47.
  135. Oong XY, Ng KT, Lam TTY, Pang YK, Chan KG, Hanafi NS, Kamarulzaman A, Tee KK. Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014. PloS ONE 2015;10(8), p.e0136254
  136. Oyomopito RA, Chen YJ, Sungkanuparph S, Kantor R, Merati T, Yam WC, Sirisanthana T, Li PC, Kantipong P, Phanuphak P, Lee CK, Kamarulzaman A, Ditangco R, Huang SW, Sohn AH, Law M, Chen YM. Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. Kaohsiung J Med Sci. 2015 Sep;31(9):445-53.
  137. Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32
  138. Saeidi A, Chong YK, Yong YK, Tan HY, Barathan M, Rajarajeswaran J, Sabet NS, Sekaran SD, Ponnampalavanar S, Che KF, Velu V, Kamarulzaman A, Larsson M, Shankar EM. Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cell Immunol. 2015 Sep;297(1):19-32
  139. Sarah Larney, PhD,Bradley M. Mathers, MD,Tonia Poteat, MMSc, MPH, PhD, Adeeba Kamarulzaman k and Louisa Degenhardt, PhD
  140. Tan, H. Y., Yong, Y. K., Andrade, B. B., Shankar, E. M., Ponnampalavanar, S., Omar, S. F., ... & Crowe, S. M. (2015). Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. Aids, 29(4), 421-431.
  141. Tanguay P, Kamarulzaman A, Aramrattana A, Wodak A, Thomson N, Ali R, Vumbaca G, Lai G, Chabungbam A. Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia.
  142. Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A. Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30.
  143. Tien Ng K, Takebe Y, Bee Chook J, Zhen Chow W, Gan Chan K, Abed Al-Darraji HA, Kamarulzaman A, Keng Tee K. Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep. 2015 Oct 13;5:15198.
  144. Vijay A, Bazazi AR, Yee I, Kamarulzaman A, Altice FL. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat. 2015 Jul;54:29-36.
  145. Wright ST, Law MG, Cooper DA, Keen P, McDonald A, Middleton M, Woolley I, Kelly M, Petoumenos K; Australian HIV Observational Database. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015 Apr 10;18:19463
  146. Harry Jin, Valerie A. Earnshaw, Jeffrey A. Wickersham, Adeeba Kamarulzaman, Mayur M. Desai, Jacob John & Frederick L. Altice 2014. An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV,DOI: 10.1080/09540121.2014.894616
  147. Ong, L. Y., Razak, S. N. H., Lee, Y. M., Sri La Sri Ponnampalavanar, S., Syed Omar, S. F., Azwa, R. I., ... & Kamarulzaman, A. (2014). Molecular diversity of HIV 1 and surveillance of transmitted drug resistance variants among treatment Na ve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. Journal of medical virology, 86(1), 38-44.
  148. Tan, H. Y., Yong, Y. K., Lim, S. H., Ponnampalavanar, S., Omar, S. F., Pang, Y. K., ... & French, M. A. (2014). Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes. Sexual health, 11(6), 532-539.
  149. Abed Al-Darraji HA, Abd Razak H, Ng KP, Altice FL, Kamarulzaman A
  150. Chow WZ, Ong LY, Razak SH, Lee YM, Ng KT, Yong YK, Azmel A, Takebe Y, Al-Darraji HA, Kamarulzaman A, Tee KK
  151. Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros P, Ford N.
  152. Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A
  153. Kamarulzaman A
  154. Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies.
  155. Larsson M, Shankar EM, Che KF, Saeidi A, Elleg R, Barathan M, Velu V, Kamarulzaman A.
  156. Lee SS, Meintjes G, Kamarulzaman A, Leung CC
  157. Lim SH, Bazazi AR, Sim C, Choo M, Altice FL, Kamarulzaman A
  158. Lubis R, Bulgiba A, Kamarulzaman A, Hairi NN, Dahlui M, Peramalah D
  159. Mohd Zim MA, Sam IC, Omar SF, Cahn YF,Abu Bakar S,Kamarulzaman A. Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2013
  160. Ng KT, Lee YM, Al-Darraji HA, Xia X, Takebe Y, Chan KG, Lu L, Mahadeva S, Kamarulzaman A, Tee KK.
  161. Ng KT, Ong LY, Lim SH, Takebe Y, Kamarulzaman A, Tee KK
  162. Reena Rajasuriara,Gabriela Khouryc,Adeeba Kamarulzaman, Martyn A. Frenche,Paul U.Cameronc,and Sharon R. Lewinc
  163. Wickersham JA,Zahari MM,Azar MM,Kamarulzaman A,Altice FL
  164. Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia- Pacific HIV Observational Database (APHOD).
  165. Aghafar MZ, Witt C, Kamarulzaman A, Ismail R, Lederman MM, Rodriguez B, Senitzer D, Lee S, Price P. Tissue Antigens. 2012 May;79(5):367-71. doi: 10.1111/j.1399-0039.2012.01843.x. Epub 2012 Feb 2.
  166. Al-Darraji HA, Kamarulzaman A, Altice FL. Int J Tuberc Lung Dis. 2012 Jul;16(7):871-9. Epub 2012 Mar 7.
  167. Azzoni L, Foulkes AS, Liu Y, Li X, Johnson M, Smith C, Kamarulzaman AB, Montaner J, Mounzer K, Saag M, Cahn P, Cesar C, Krolewiecki A, Sanne I, Montaner LJ. PLoS Med. 2012;9(4):e1001207. Epub 2012 Apr 17.
  168. Chong YB, Tan LP, Robinson S, Lim SK, Ng KP, Keng TC, Kamarulzaman A. Penicilliosis in lupus patients presenting with unresolved fever: A report of 2 cases and literature review. Tropical Biomedicine 29(2):270- 276 (2012)
  169. Chow WZ, Al-Darraji H, Lee YM, Takebe Y, Kamarulzaman A, Tee KK.
  170. Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A,duCros P.
  171. Ford N, Singh K, Cooke GS, Mills EJ, von Schoen- Angerer T, Kamarulzaman A, du Cros P. Clin Infect Dis. 2012 May;54(10):1465-72. Epub 2012 Mar 19.
  172. Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A. Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18.
  173. Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance
  174. Jeffrey A Wickersham,Ruthanne Marcus,Adeeba Kamarulzaman, Muhammad Muhsin Zaharib & Frederick L Altice
  175. Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; On behalf of the TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582.
  176. Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database. J Int AIDS Soc. 2012 Jan 26;15(1):1.
  177. Ng KT, OngLY, Takabe Y, Kamarulzaman A, Tee KK,
  178. Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; on behalf of the TREAT Asia Studies to Evaluate Resistance (TASER) and the TREAT Asia HIV Observational Database. Evaluating immunologic response and clinical deterioration in treatment-na patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2012 Nov 7
  179. Sam IC, Karunakaran R, Kamarulzaman A, Ponnampalavanar S, Syed Omar SF, Ng KP, Mohd Yusof MY, Hooi PS, Jafar FL, Abubakar S. A large exposure to Brucella melitensis in a diagnostic laboratory. J Hosp Infect 2012; 80(4):321-5.
  180. Smolak A, Gorroochurn P, Kamarulzaman A, Janjua N
  181. Tee KK, Kamarulzaman A, Matano T, Takebe Y. Future Virol. (2012) 7(4), 405-414
  182. Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217. Epub 2012 Feb 22.
  183. Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend. 2011 Jan 11.
  184. Kanter J, Koh C, Razali K, Tai R, Izenberg J, Rajan L, Van Griensven F, Kamarulzaman A. Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7.
  185. Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis. 2011 Apr 15;52(8):1053-7.
  186. Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French M, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS. 2011 Jul 31;25(12):1455-60
  187. Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Robust interferon- nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol. 2011May;139(2):115-21. Epub 2011 Feb 23
  188. Tan LH, Fong MY, Mahmud R, Muslim A, Lau YL, Kamarulzaman A. (2011). Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 60: 111-113
  189. Adeeba Kamaruzzaman & Shaikh Mohd Saifuddeen. 2010. Islam and harm reduction. International Journal of Drug Policy 21(2): 115-118.
  190. Altice FL,Kamarulzaman A, Soriano W,Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010 Jul 31;376(9738):367-87
  191. Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., Friedland, G. H. 2010. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs Lancet. (Tier 1, Impact Factor = 30.758)
  192. Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to Act : a call for comprehensive responses to HIV in people who use drugs.Lancet.2010Jul 20
  193. Beyer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet . 2010 Jul 24;376(9737):208-11
  194. Bux SI, Mohd. Ramli N, Ahmad Sarji S, Kamarulzaman A CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE Biomed Imaging Interv J 2010; 6(4):e35
  195. CE Lee, K Adeeba, G Freigang Human Plasmodium Knolesi Infections in Klang Valley, Peninsula Malaysia : A Case Series Med J Mal Vol 65 No 1 , March 2010
  196. Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S,Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.doi: 10.1111/j.1399- 0039.2010.01570.x. [Epub ahead of print] PubMed PMID: 20887379
  197. Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010 Jun;21 (6):416-23
  198. Fong, M. Y., Wong, K. T., Rohela, M., Tan, L. H., Adeeba, K., Lee, Y. Y., Lau, Y. L., et al. 2010. Unusual manifestation of cutaneous toxoplasmosis in a HIV-positive patient Tropical Biomedicine. (Tier 4, Impact Factor = 0.649)
  199. Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy. 2010 Mar;21(2):115-8. Epub 2009 Dec 16.
  200. Lau KA, Wang B, Miranda-Saksena M, Boadle R, Kamarulzaman A, Ng KP, Saksena NK. Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res. 2010 Apr 1;8(3):259-71.
  201. Li Y, Tee KK, Liao H, Hase S, Uenishi R, Li XJ, Tsuchiura T, Yang R, Govindasamy S, Yong YK, Tan HY, Pybus OG, Kamarulzaman A, Takebe Y. Identification of a Novel Second- Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. J Acquir Immune Defic Syndr. 2010 Apr 7.
  202. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-28.
  203. Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, Wong MH, Syed Omar SF, Hussain SH. High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect. 2010 Aug 11.
  204. Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J,Sirisanthana T, Chen YM, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; on behalf of The TREAT Asia HIV Observational Databse. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 2010 Mar 21
  205. Sam, I., Kamarulzaman, A., Ong, G., Veriah, R. S., Ponnampalavanar, S., Chan, Y. F., & AbuBakar, S. (2010). Research note chikungunya virus-associated death in Malaysia. Tropical biomedicine, 27(2), 343-347.
  206. Takebe Y, Liao H, Hase S, Uenishi R, Li Y, Li XJ, Han X, Shang H, Kamarulzaman A, Yamamoto N, Pybus OG, Tee KK. Reconstructing the chronology of the expansion of HIV-1 in East Asia: the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC. Vaccine. 2010 May 26;28 Suppl 2:B39-44.
  207. Takebe, Y., Liao, H. N., Hase, S., Uenishi, R., Li, Y. E., Li, X. J., Kamarulzaman, A., Tee, K. K., et al. 2010. Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: The relevance of genetic diversity and phylodynamics for vaccine strategies Vaccine. (Tier 1, Impact Factor = 3.616)
  208. Tan DBA, Yong YK, Tan HY, French M, Kamarulzaman A, et al. (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS Clinic Res 1:102 doi:10.4172/2155-6113.1000102
  209. Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010 Apr;84(7):3339-50. Epub 2010 Jan 20.
  210. Yue Li, BSc,Kok Keng Tee, PhD,Huanan Liao,PhD,Saiki Hase, PhD,Rie Uenishi,PhD,Xiao-Jie Li, MD, PhD,Takayo Tsuchiura, BSc,Rongge Yang, MD, PhD,Sumathi Govindasamy, BA,Yean Kong Yong, MMedSc, Hong Yien Tan, MMedSc,Oliver G. Pybus, PhD,k Adeeba Kamarulzaman,MBBS, FRACP,and Yutaka Takebe, MD, PhD.Identification of a Novel Second-Generation Circulating .Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B. Feb 2010
  211. Zahari MM, Bae WH, Zainal NZ, Habil H, Kamarulzaman A, Altice FL.Psychiatric and Substance Abuse Co-Morbidity Among HIV Seropositive and HIV Seronegative Prisoners in Malaysi. Am J Drug Alcohol Abuse.Jan;36(1);31-8
  212. Zahari, M. M., Bae, W. H., Zainal, N. Z., Habil, H., Kamarulzaman, A., Altice, F. L. 2010. Psychiatric and Substance Abuse Comorbidity among HIV Seropositive and HIV Seronegative Prisoners in Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.335)
  213. Zhou, J. L., Sirisanthana, T., Kiertiburanakul, S., ..., Kamarulzaman, A., et al. 2010. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.55)
  214. Benito N, Mir JM, de Lazzari E, Cabell CH, del R A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94
  215. Benito, N., Miro, J. M., de Lazzari, E., ..., Kamarulzaman, A., et al. 2009. Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition Annals of Internal Medicine. (Tier 1, Impact Factor = 17.457)
  216. Bruce, R. D., Govindasamy, S., Sylla, L., Kamarulzaman, A., Altice, F. L. 2009. Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market American Journal of Drug and Alcohol Abuse. (Tier 3, Impact Factor = 1.094)
  217. Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009 Jul 28;73(4):315-20.
  218. Cherry, C. L., Affandi, J. S., Imran, D., Yunihastuti, E., Smyth, K., Vanar, S., Kamarulzaman, A., Price, P. 2009. Age and height predict neuropathy risk in patients with HIV prescribed stavudine Neurology. (Tier 1, Impact Factor = 7.043)
  219. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kone P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Mir JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008 Oct 27;168(19):2095-103
  220. Egger, S., Petoumenos, K., Kamarulzaman, A., Hoy, J., Sungkanuparph, S., Chutah, J., Falster, K., Zhou, J. L., Law, M. G. 2009. Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD) Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57)
  221. Kamarulzaman A, Antiretroviral therapy in Malaysia; identifying barriers to universal access HIV Therapy. Nov , Vol. 3, No. 6, Pages 573-582
  222. Kamarulzaman A, Impact of HIV Prevention Programs on Drug Users in Malaysia . J Acquir Immune Defic Syndr .Nov;52 Suppl 1;S17-9
  223. Kamarulzaman, A. 2009. Impact of HIV Prevention Programs on Drug Users in Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes. (Tier 1, Impact Factor = 4.57)
  224. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV- infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis. 2009 Apr 1;48(7):940-50
  225. Srasuebkul, P., Lim, P. L., Lee, M. P., ..., Kamarulzaman, A., et al. 2009. Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database Clinical Infectious Diseases. (Tier 1, Impact Factor = 8.266)
  226. Tee KK, Kusagawa S, Li XJ, Onogi N, Isogai M, Hase S, Uenishi R, Liao H, Kamarulzaman A, Takebe Y. Isolation and characterization of a replication- competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B)PLoS One. Aug 18;4 (8).
  227. Tee KK, Pybus OG, Parker J, Ng KP, Kamarulzaman A, Takebe Y.Estimating the date of origin of an HIV-1 circulating recombinant form.Virology. 2009 Mar 7.
  228. Tee KK, Takebe Y, Kamarulzaman A. Emerging and re- emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2009 May;13(3):307-18.
  229. Tee, K. K., Pybus, O. G., Parker, J., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2009. Estimating the date of origin of an HIV-1 circulating recombinant form Virology. (Tier 2, Impact Factor = 3.539)
  230. Tee, K. K., Takebe, Y., Kamarulzaman, A. 2009. Emerging and re-emerging viruses in Malaysia, 1997-2007 International Journal of Infectious Diseases. (Tier 3, Impact Factor = 2.210)
  231. Zhou, J. L., Elliott, J., Li, P. C. K., ..., Kamarulzaman, A., et al. 2009. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database Bmc Infectious Diseases. (Tier 2, Impact Factor = 2.536)
  232. 33.Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
  233. Baddley JW, Benjamin DK Jr, Patel M, Mir J, Athan E, Barsic B, Bouza E,Clara L, Elliott T, Kanafani Z, Klein J, Lerakis S, Levine D, Spelman D,Rubinstein E, Tornos P, Morris AJ, Pappas P, Fowler VG Jr, Chu VH, Cabell C; International Collaboration on Endocarditis- Prospective Cohort Study Group (ICE - PCS).Eur J Clin Microbiol Infect . Candida infective endocarditis. Dis. 2008 Jul;27(7):519-29.
  234. Baskaran, N. D., Gan, G. G., Adeeba, K. 2008. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients Annals of Hematology. (Tier 2, Impact Factor = 2.342)
  235. Bruce RD, Govindasamy S, Sylla L, Haddad MS, Kamarulzaman A, Altics FL. Case Series of Buprenorphine Injectors in Kuala Lumpur, Malaysia. AM J Drug Alcohol Abuse. 2008;24(4):511-7
  236. Bruce, R. D., Govindasamy, S., Sylla, L., Haddad, M. S., Kamarulzaman, A., Altice, F. L. 2008. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia American Journal of Drug and Alcohol Abuse. (Tier 2, Impact Factor = 1.236)
  237. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Kamarulzaman A, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med. 2008 Oct 27; 168(19):2095-103
  238. Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1139-45.
  239. Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
  240. Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2008. Continuous crossover(s) events of HIV-1CRF01_AE and B subtype strains in Malaysia: Evidence of rapid and extensive HIV-1 evolution in the region Current Hiv Research. (Tier 2, Impact Factor = 2.653)
  241. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Nov 15;372(9651):1733-45
  242. Sherman SG, Kamarulzaman A, Spittal P.Women and drugs across the globe: a call to action. Int J Drug Policy. 2008 Apr;19(2):97-8.
  243. Sherman, S. G., Kamarulzaman, A., Spittal, P. 2008. Women and drugs across the globe: A call to action International Journal of Drug Policy. (Tier 2, Impact Factor = 1.272)
  244. Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, James I, French M, Price P. Immunological Profiles of Immune Restoration Disease Presenting as Mycobacterial Lymphadenitis and Cryptococcal Meningitis. HIV Med. 2008 May;9(5):307-16
  245. Tan, D., Yong, Y., Tan, H., Kamarulzaman, A., Tan, L., Lim, A., et al. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis Hiv Medicine. (Tier 1, Impact Factor = 3.347)
  246. Tee KK, Pybus OG, Li XJ, Han X, Shang H, Kamarulzaman A, Takebe Y. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol. 2008 Sep;82(18):9206-15.
  247. Tee KK, Pybus OG, Liao H, Uenishi R, Hase S, Kamarulzaman A, Li XJ, Takebe Y.Chronology of the HIV- 1 CRF07_BC expansion in East Asia. AIDS. 2008 Jan 2;22(1):156-8.
  248. Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis. 2008 Nov 13
  249. Tee, K. K., Pybus, O. G., Li, X. J., Han, X. X., Shang, H., Kamarulzaman, A., et al. 2008. Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia Journal of Virology. (Tier 1, Impact Factor = 5.332)
  250. Tee, K. K., Pybus, O. G., Liao, H., Uenishi, R., Hase, S., Kamarulzaman, A., et al. 2008. Chronology of the HIV-1CRF07_BC expansion in East Asia Aids. (Tier 1, Impact Factor = 5.842)
  251. Wright E, Brew B, Arayawichanont A, Robertson k, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffman S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, dwyer R, McCormack G, Hellard M, Cherry C, Mc Arthur J, Wesselingh S. Neurologic Disorders are Prevalent in HIV-posotive Outpatients in the Asia-Pacific Region. Neurology. 2008 Jul 1;71(1):50-6.
  252. Wright, E., Brew, B., Arayawichanont, A., Robertson, K., Samintharapanya, K., Kongsaengdao, S., et al. 2008. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region Neurology. (Tier 1, Impact Factor = 6.014)
  253. Baskaran, N. D., Gan, G. G., Adeeba, K., Sam, I. C. 2007. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia International Journal of Infectious Diseases
  254. Lau, K. A., Wang, B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Near full-length sequence analysis of a unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia Aids Research and Human Retroviruses
  255. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS. 2007 Jul 31;21(12):1525-34.
  256. Lim, A., Tan, D., Price, P., Kamarulzaman, A., Tan, H. Y., James, I., French, M. A. 2007. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy Aids
  257. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007 Mar;18(2):136-40
  258. Reid, G., Kamarulzaman, A., Sran, S. K. 2007. Malaysia and harm reduction: The challenges and responses International Journal of Drug Policy
  259. Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007 Aug;18(4):306-12
  260. Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A. Emerging HIV Epidemics in Muslim Countries: Assessment of Different Cultural Responses to Harm Reduction and Implications for HIV Control. Cur HIV/AIDS Rep. 2007 Dec;4(4):151-7
  261. Wang B, Lau KA, Ong LY, Shah M, Steain MC, Foley B, Dwyer DE, Chew CB, Kamarulzaman A, Ng KP, Saksena NK. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology. 2007 Oct 25;367(2):288-97.
  262. Wang, B., Lau, K. A., Ong, L. Y., Shah, M., Steam, M. C., Foley, B., Dwyer, D. E., Chew, C. B., Kamarulzaman, A., Ng, K. P., Saksena, N. K. 2007. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: Evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants Virology
  263. Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 2007 Jan;8(1):8-16.
  264. Zhou, J., Paton, N. I., Ditangco, R., Chen, Y. M., Kamarulzaman, A., Kumarasamy, N., Lee, C. K. C., Li, P. C. K., Merati, T. P., Phanuphak, P., Pujari, S., Vibhagool, A., Zhang, F., Chuah, J., Frost, K. R., Cooper, D. A., Law, M. G. 2007. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database Hiv Medicine
  265. Lau KA, Wang B, Kamarulzaman A, Ng KP, Saksena NK. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res. 2008 Mar;6(2):108-16
  266. Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. J Postgrad Med. 2006 Jan-Mar;52(1):23-9;
  267. Raja, N. S., Parasakthi, N., Puthucheary, S. D., Kamarulzaman, A. 2006. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Journal of Postgraduate Medicine
  268. Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol. 2006 Jun;195(2):107-12.
  269. Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb;22(2):121-4.
  270. Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):523-9.
  271. Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia Aids Research and Human Retroviruses
  272. Tee, K. K., Kamarulzaman, A., Ng, K. P. 2006. Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia Medical Microbiology and Immunology
  273. Tee, K. K., Li, X. J., Nohtomi, K., Ng, K. P., Kamarulzaman, A., Takebe, Y. 2006. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia Jaids-Journal of Acquired Immune Deficiency Syndromes
  274. Zhou, M. L., Phanupak, P., Kiertiburanakul, S., Ditangco, R., Kamarulzaman, A., Pujary, S., et al. 2006. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database Jaids-Journal of Acquired Immune Deficiency Syndromes
  275. Adeeba Kamarulzaman .Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. 2005, Med. J. Malaysia, Vol. 60, no. 1, pg. 1-4
  276. Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A. Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol. 2005 Jan;26(1):100-4.
  277. Joazlina ZY, Wastie ML, Kamarulzaman A. Kostmann's syndrome. Clin Imaging. 2005 Sep-Oct;29(5):364-6.
  278. Joazlina, Z. Y., Wastie, M. L., Kamarulzaman, A. 2005. Kostmanns syndrome Clinical Imaging
  279. Nurul Atifah MA, Loo HK, Subramaniam G, Wong EH, Selvi P, Ho SE, Kamarulzaman A, Parasakthi N. Faecal prevalence of extended-spectrum Beta-lactamase (ESBL)-producing coliforms in a geriatric population and among haematology patients. Malays J Pathol. 2005 Dec;27(2):75-81.
  280. Ranganathan S, Moosa F, Kamarulzaman A, Looi LM. MRI and CT findings of cryptococcal vaginitis. 2005, Br. J. Radiol., Vol. 78, no. 928, pg. 353-354
  281. Ranganathan, S., Moosa, F., Kamarulzaman, A., Looi, L. M. 2005. MRI and CT findings of cryptococcal vaginitis British Journal of Radiology
  282. Tee KK, Pon CK, Kamarulzaman A, Ng KP. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS. 2005 Jan 28;19(2):119-26.
  283. Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50.
  284. Tee KK, Saw TL, Pon CK, Kamarulzaman A, Ng KP. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses. 2005 Dec;21(12):1046-50.
  285. Tee, K. K., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia Aids
  286. Tee, K. K., Saw, T. L., Pon, C. K., Kamarulzaman, A., Ng, K. P. 2005. The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia Aids Research and Human Retroviruses
  287. Vinothini. A, Khoo, E.M. & Adeeba, K. 2005. Knowledge of HIV/AIDs in among pregnant women in an urban health clinic - a preliminary study. The Family Physician 13(1&2): 10-15
  288. Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG, The TREAT Asia HIV Observational Database: Baseline and Retrospective Data, 2005, J. Acquir. Immune Defic. Syndr., Vol. 138, no. 2, pg. 174-179
  289. Zhou, J., Kumarasamy, N., Ditangco, R., Kamarulzaman, A., Lee, C. K. C., Li, P. C. K., et al. 2005. The TREAT Asia HIV observational database - Baseline and retrospective data Jaids-Journal of Acquired Immune Deficiency Syndromes
  290. Kamarulzaman A. Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Healt. 2004;16(1):1-2
  291. Oh WS, Suh JY, Song JH, Ko KS, Jung SI, Peck KR, Lee NY, Yang Y, Chongthaleong A, Chiu CH, Kamarulzaman A, Parasakthi N, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Carlos CC; ANSORP Study Group. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist. 2004 Spring;10(1):37-42
  292. Song JH, Jung SI, Ki HK, Shin MH, Ko KS, Son JS, Chang HH, Kim SW, Lee H, Kim YS, Oh WS, Peck KR, Chongthaleong A, Lalitha MK, Perera J, Yee TT, Jamal F, Kamarulzaman A, Carlos CC, So T; Asian Network for Surveillance of Resistant Pathogens Study Group. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis. 2004 Jun 1;38(11):1570-8
  293. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A, Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, Ng TK, Shibl A. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7.
  294. Gan GG, Kamarulzaman A, Goh KY, Ng KP, Na SL, Soo-Hoo TS. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia. 2002 Mar;57(1):118-22.
  295. Nissapatorn V, Kamarulzaman A, Init I, Tan LH, Rohela M, Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia. 2002 Sep;57(3):304-10.
  296. Tan LH, Kamarulzaman A, Liam CK, Lee TC. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol. 2002 Oct;23(10):584-90.
  297. Tan YM, Goh KL, Kamarulzaman A, Tan PS, Ranjeev P, Salem O, Vasudevan AE, Rosaida MS, Rosmawati M, Tan LH. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002 Feb;55(2):276-8.
  298. Tan, L. H., Kamarulzaman, A., Liam, C. K., Lee, T. C. 2002. Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia Infection Control and Hospital Epidemiology
  299. Tan, Y. M., Goh, K. L., Kamarulzaman, A., Tan, P. S., Ranjeev, P., Salem, O., et al. 2002. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate Gastrointestinal Endoscopy
  300. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, Chew NK, Chua KB, Lam SK. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3.
  301. Chong, H. T., Kamarulzaman, A., Tan, C. T., Goh, K. J., Thayaparan, T., Kunjapan, R., Chew, N. K., Chua, K. B., Lam, S. K. 2001. Treatment of acute Nipah encephalitis with ribavirin Annals of Neurology
  302. Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001 Jan;42(1):40-3.
  303. Chua, K. B., Lam, S. K., Goh, K. J., Hooi, P. S., Ksiazek, T. G., Kamarulzaman, A., Olson, J., Tan, C. T. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia Journal of Infection
  304. Chua KB, Lam SK, Tan CT, Hooi PS, Goh KJ, Chew NK, Tan KS, Kamarulzaman A, Wong KT. High mortality in Nipah encephalitis is associated with presence of virus in cerebrospinal fluid. Ann Neurol. 2000 Nov;48(5):802-5.
  305. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35.
  306. Goh, K. J., Tan, C. T., Chew, N. K., Tan, P. S. K., Kamarulzaman, A., Sarji, S. A., et al. 2000. Clinical features of nipah virus encephalitis among pig farmers in Malaysia New England Journal of Medicine
  307. Tan SY, Tan LH, Teo SM, Thiruventhiran T, Kamarulzaman A, Hoh HB. Disseminated nocardiosis with bilateral intraocular involvement in a renal allograft patient. Transplant Proc. 2000 Nov;32(7):1965-6.
  308. Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999 Oct 9;354(9186):1257-9
  309. Chua, K. B., Goh, K. J., Wong, K. T., Kamarulzaman, A., Tan, P. S. K., Ksiazek, T. G., et al. 1999. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia Lancet
  310. Pakianathan MR, Kamarulzaman A, Ismail R, McMillan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS. 1999 Sep 10;13(13):1787-8. No abstract available
  311. Pakianathan, M. R., Kamarulzaman, A., Ismail, R., McMillan, A., Scott, G. R. 1999. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients Aids
  312. Kamarulzaman A, Briggs RJ, Fabinyi G, Richards MJ. Skull osteomyelitis due to Salmonella species: two case reports and review. Clin Infect Dis. 1996 Apr;22(4):638-41.
Books
  1. Is It HIV ? A handbook for healthcare providers. Australasian Soceity for HIV Medicine & Treat Sia . 2009, Editor
  2. Rapid Situation Assessment of Malaysia 2004, G Reid, A Kamarulzaman, S Kaur . 1-41
  3. University Hospital Antibiotic Policy and Guidelines 2004 - 2006 . Editors A kamarulzaman , N Parasaktthi
  4. Consensus Guidelines on the Management of Staphylococcus aureus infections . Editor A Kamarulzaman . April 2000
  5. 1st National Consensus Guidelines on Antiretroviral Therapy. October 1998 Editors C Lee, A Kamarulzaman, M Alias, N Othman
Chapter in Books
  1. Ng CW, Mohd Hairi NN, Ng CJ, Kamarulzaman A. 2016. Universal Health Coverage in Malaysia: Issues and Challenges. In Tey NP, Cheong KC, Rasiah R (eds). Revisiting Malaysia's Population-Development Nexus. The Past in Its Future. Kuala Lumpur: University of Malaya Press.
  2. A Kamarulzaman, K Razali. The HIV epidemic in Malaysia. Public Health Aspects of HIV/AIDS in Developing Countries: Epidemiology, Prevention and Care. Editors C Beyrer, D Celentano Springer, New York 2008.
  3. A Kamarulzaman. Sepsis. Management aspects of acute care. Eds: Chan YK, Ng KP. 2006:179-187
  4. P du Cros, A Kamarulzaman. HIV and Tuberculosis Coinfection. Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. Editor: M Curtis. International Harm Reduction Development Program. Open Society Institute. 2006
  5. A Kamarulzaman. Common viral infections in Aisa . Principles and Practice of clinical Medicine in Asia. Treating the Asian Patient. Eds : JJY Sung, LKS Wong, PKT Li, J Sanderson, TCY Kwok. 2nd Edn : 2002
  6. A Kamarulzaman, J Hoy. Cryptosporidia and microsporidia. In Fairfield Hospital HIV Handbook. Eds: F Bowden, A Mijch 1995; 43-44
Other Publications
  1. Her World Power list: 6 most inspiring women of Singapore and Malaysia - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  2. Malay Mail - Monash Honarary Doctorate Award - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  3. Rawatan penagih lebih baik di luar penjara - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  4. Metro Ahad / Karisma - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  5. AN EVENING OF GLAMOUR AND GOODWILL THE MALAYSIAN AIDS COUNCIL ANNUAL - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  6. Adeeba Kamarulzaman and Bertrand Union . Winds of change on drug policy - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  7. Adeeba Kamarulzaman,Reena Rajasuriar - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  8. Adeeba Kamarulzaman. Penghidap HIV turun - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  9. FRONTLINER FOR HIV AIDS PROFESSOR DR ADEEBA KAMARULZAMAN ON THE CAUSE CLOSE TO HER HEART - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  10. Foundation receives RM25,000 - NST - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  11. THE THIN RED LINE - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  12. The female face of HIV/AIDS - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  13. New York Times : Towards an AIDS-Free World - Mass Media(Newspaper,Radio,Tv,Popular Magazine)

RESEARCH PROJECT

National
  1. 2022 - 2025, Fundamental Research Grant Scheme (FRGS)
    Investigating The Alteration Of Mitochondrial Metabolism Associated With CD8+ T Cell Exhaustion ( Co-Researcher)
  2. 2020 - 2023, Others MOHE - Top 100 (IIRG)-HWB
    Implementation Of A Community- Based, Patient Navigation Model To Engage People Who Inject Drugs (pwid) Into Hiv Prevention And Treatment Services ( Co-Researcher)
  3. 2020 - 2023, Others MOHE - Top 100 (IIRG)-HWB
    Enabling Data Linkage To Assess Health Outcomes Among Pwid Engaged In A Community-based Intervention ( Principal Investigator(PI))
  4. 2021 - 2023, Partnership Grant
    Using A Popular Teletraining Platform To Reduce Clinician Stigma And Disparities In Hiv Testing, Prevention And Linkage To Care In Malaysia ( Principal Investigator(PI))
  5. 2022 - 2024, Allianz Malaysia Berhad
    Assessment of Post-acute COVID Syndrome (PACS) and Serological Response in Confirmed COVID-19 Patients in the University of Malaya Medical Centre ( Principal Investigator(PI))
  6. 2021 - 2023, GRANT FROM DEPARTMENT OF MEDICINE (DOM)
    Evaluation of gaps in Cervical Cancer Screening and Prevention among women living with HIV (WLHIV) in a tertiary teaching hospital in Malaysia ( Co-Researcher)
  7. 2015 - 2017, RU Operation
    Review Of Policy Towards Healthy Lifestyles ( Co-Researcher)
  8. 2012 - 2014, High Impact Research (HIR)
    Molecular Genetics of Respiratory Pathogens Associated with Respiratory Tract Infections (From January 2012) High Impact Research (HIR): Genetics of the Respiratory, Gastrointestinal, Central Nervous System and Blood-borne Pathogens ( Consultant)
  9. 2010 - 2012, Pfizer
    A phase 2B multicenter, randomized, comparative trial of UK-453.061 versus etravirine in combination with Darunavir/Ritonavir and a Nucleotide/Nucleoside reverse transcriptase inhibitor for the treatment of antiretroviral experienced HIV-1 infected subjects with evidence of NNRTI 0resistant HIV-1. A phase 2B/3 open-label rollover study for subjects discontinuing from the UK-453,061 protocols for the treatment of HIV-1 infected subjects. Sponsor : Pfizer ( Principal Investigator(PI))
  10. 2011 - 2012, HTMC, Flag ship
    Diseases among poverty (A community based participatory action research project) ( Consultant)
  11. 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    Social Determinants Epidemiological Routes of HIV/STI transmission Among Fishermen ( Principal Investigator(PI))
  12. 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    A prospective observational cohort study of immune reconstitution and its consequences in immunodeficient HIV-infected patients treated with highly active anti-retroviral therapy. ( Consultant)
  13. 2011 - 2011
    Strengthening Epidemic Intelligence in Malaysia ( Principal Investigator(PI))
  14. 2008 - 2008, Smith-Kline Beecham International
    An open non-comparative, multicentre study to assess the efficacy and safety of oral SB 265805 320 mg once daily for 7 days for the treatment of lower respiratory tract infections in adults. Sponsor: Smith-Kline Beecham International ( Consultant)
  15. 1999 - 2008, Sarawak Medichem Pharmaceuticals
    A Phase 1B Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV Positive Patients with No Previous Antiretroviral Therapy ( Consultant)
  16. 1999 - 2008, Grunenthal Gmbh
    Efficacy and Safety of Oral Gatifloxacin versus oral amoxacillin with a treatment duration of 7 to 10 days in patients with bacterial community acquired pneumonia ( Consultant)
  17. 1999 - 2008, IRPA
    Prophylactic versus pre-emptive therapy of cytomegalovirus infection in bone marrow and solid organ transplant patients ( Principal Investigator(PI))
  18. 2000 - 2008, ANSORP
    Clinical impact of antimicrobial resistance among invasive pneumococcal pathogens in Asian countries ( Consultant)
  19. 2000 - 2008, Bristol-Myers Squibb
    A Phase 111 study comparing the antiviral efficacy and safety of BMS-232632 with efavirenz, each in combination with fixed dose zidovudine-lamivudine ( Consultant)
  20. 2001 - 2008, Geran Penyelidikan Universiti Malaya (UMRG)
    A cross sectional survey and prospective study on tuberculin skin reaction among healthcare workers at University Malaya Medical Centre ( Consultant)
  21. 2008 - 2008, PFIZER Inc
    A randomized, open label, comparative multicenter study of voriconazole versus conventional amphotericin B followed by fluconazole in the treatment of candidaemia in non neutropaenic subjects ( Consultant)
  22. 2001 - 2008, Eli - Lily
    LY333328 versus vancomycin in complicated skin/skin-structure infections. Protocol H4Q-MC-ARRI ( Consultant)
  23. 2003 - 2008, National Institute of Health, USA
    A Multi-faceted Study of HIV in Malaysia CIPRA R03 AI 56379-01 ( Principal Investigator(PI))
  24. 2004 - 2008, GSK
    A prospective randomized, double-blind, placebo- controlled, dose ranging, multi-center study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram negative severe sepsis in adults ( Consultant)
  25. 2003 - 2008, amfAR
    TREAT Asia Observational Database ( Consultant)
  26. 2004 - 2008, Pfizer
    Linezolid In The Treatment of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus Protocol: A5951001 ( Co-Researcher)
  27. 2008 - 2008, ICE
    International Collaboration on Endocarditis (ICE) Prospective Cohort Study of Infective Endocarditis ( Consultant)
  28. 2004 - 2008, University of Western Australia
    Immune Reconstitution Disease in Severely Immuno- deficient AIDS patients commencing HAART Collaborator: University of Western Australia ( Principal Investigator(PI))
  29. 2005 - 2008, Japan Foundation for AIDS Prevention
    International collaborative study on epidemiological survey of HIV infections, isolation and characterisation of unique HIV-1 recombinants emerging in Malaysia. ( Principal Investigator(PI))
  30. 2005 - 2008, Tibotec
    A randomized, controlled, open label-label trial to compare the efficacy, safety and tolerability of TMC114/RTV versus LPV/RTV in treatment- experienced HIV-infected subjects Protocol: TMC114-214 ( Consultant)
  31. 2008 - 2008, NCHECR, University of New South Wales
    A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study ( Consultant)
  32. 2006 - 2008, TREAT Asia
    Evaluation of Transmitted HIV Drug Resistance in Treatment Na ve, Recently Infected HIV Individuals. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER S ( Consultant)
  33. 2007 - 2008, ScienceFund
    Genotypic and Phenotypic Characterization of Novel Human Immunodeficiency Virus Type 1 (HIV-1) Circulating Recombinant Form (CRF33_01B) in Malaysia ( Principal Investigator(PI))
  34. 2008 - 2008, Geran Penyelidikan Universiti Malaya (UMRG)
    Pilot Project: Introducing Methadone and HAART for Soon To Be Released HIV-Positive Prisoners in Pengkalan Chepa Kelantan ( Consultant)
  35. 2008 - 2008, National Institutes on Drug Abuse, USA
    Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Sponsor: National Institutes on Drug Abuse, USA ( Principal Investigator(PI))
Private
  1. 2022 - 2024, Private Funding
    Research And Educational Activities To Increase Vaccination Awareness In Malaysia ( Principal Investigator(PI))
International
  1. 2020 - 2025, International Funding
    Malaysian Implementation Science Training (mist) Program In Hiv ( Principal Investigator(PI))
  2. 2020 - 2025, International Funding
    Implementing Stigma Reduction Tools Via A Popular Teletraining Platform To Reduce Clinician Stigma And Disparities In Hiv Testing, Prevention, And Linkage To Care In Malaysia ( Principal Investigator(PI))
  3. 2020 - 2025, International Funding
    Developing An Artificial Intelligence-based Mhealth Intervention To Increase Hiv Testing In Malaysia ( Principal Investigator(PI))
  4. 2021 - 2025, International Funding
    Development And Testing Of A Mobile Application To Enhance Hiv Prevention Cascade In Malaysia Msm ( Principal Investigator(PI))
  5. 2022 - 2025, International Funding
    Improving Hiv Testing And Prep For Transgender Women Through Mhealth ( Principal Investigator(PI))
  6. 2023 - 2025, International Funding
    Strengthening The Hiv Care Continuum For Transgender Women Living With Hiv In Malaysia ( Co-Researcher)
  7. 2022 - 2025, USA NIH R34
    Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men, United States Agency for International Development ( Co-Researcher)
  8. 2020 - 2024, CHINESE UNIVERSITY HONG KONG
    Functional decline and quality of life in people aging with HIV in Asia ( Co-Researcher)
  9. 2016 - 2024, International Funding
    Addiction, Hiv And Tuberculosis In Malaysian Criminal Justice Settings ( Principal Investigator(PI))
  10. 2018 - 2024, International Funding
    Developing An International Master's Of Research Ethics Program In Malaysia ( Principal Investigator(PI))
  11. 2020 - 2024, International Funding
    Developing An Artificial Intelligence Chatbot To Promote Hiv Testing ( Principal Investigator(PI))
  12. 2021 - 2024, International Funding
    Asean Sero-surveillance Study On Covid-19 Vaccines Work Plan ( Co-Researcher)
  13. 2022 - 2023, International Funding
    Young People's Opinions On Drug Policy, And Drug Use Trends And Hiv Risk Behaviours In Malaysia ( Principal Investigator(PI))
  14. 2022 - 2023, International Funding
    Implementation Of A Pharmacy-based Hiv Pre-exposure Prophylaxis (prep) Service Delivery To Increase Prep Uptake In Malaysia ( Principal Investigator(PI))
  15. 2013 - 2015, National Medical Research Council (NMRC) Singapore
    Adult Dengue Platelet Study (ADEPT) ( Consultant)
  16. 2006 - 2012, NCHECR, University of New South Wales
    A randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Conmbinations Antiretroviral Regimens as Initial Therapy for HIV Infection. The Altair Study ( Principal Investigator(PI))
  17. 2011 - 2011, WHO
    A Multicentre Study To Validate The Predictive Value Of Warning Signs In Dengue ( Consultant)
  18. 2008 - 2008, Pharmaceutical company (Pfizer)
    ZEPHYR study ( Principal Investigator(PI))
  19. 2006 - 2008, TREAT Asia
    Monitoring and Evaluation of HIV Drug Resistance in Patients on Antiretroviral Therapy. TREAT Asia Studies to Evaluate Resistance (TASER) Protocol: TASER M. ( Consultant)

CONSULTANCY PROJECT

  • Who 2013 Consolidated Guidelines On The Use of Antiretroviral for The Treatment and Prevention of Hiv, WHO
    01 Sep 2013 - 01 Sep 2013 (International)
  • Consultation On Ethics in Conducting Research in People Who Use Drugs- Unaids. Istanbul, UNAIDS
    01 Sep 2010 - 01 Sep 2010 (International)
  • Consultation On Ethics in Conducting Research in People Who Use Drugs 2 - Unaids, Who. Kuala Lumpur , December 2010, WHO
    01 Jan 2010 - 01 Jan 2010 (International)
  • Meeting On The Development of The Regional Strategy for Harm Reduction in Asia and The Pacific 2010-2015 Confronting Hiv Among People Who Inject Drugs Kuala Lumpur, -
    01 Sep 2009 - 01 Sep 2009 (International)
  • Confronting Hiv Among People Who Inject Drugs - Kuala Lumpur Dec 09, Meeting on the Development of the Regional Strategy for Harm Reduction in Asia and the Pacific 2010-2015
    01 Apr 2009 - 01 Apr 2009 (International)
  • Global Advocacy for Injecting Drug Use Bill and Melinda Gates Foundation, London, Bill and Melinda Gates Foundation
    01 Sep 2008 - 01 Sep 2008 (International)
  • World Health Organisation. Hiv Testing and Counselling. Phnom Penh, World Health Organisation
    01 Sep 2007 - 01 Sep 2007 (International)
  • World Health Organisation. Hiv Testing and Counselling in Idu. Manila, World Health Organisation
    01 Sep 2007 - 01 Sep 2007 (International)
  • Institute of Medicine, National Academies of Sciences, Usa. Prevention of Hiv Infection Among Injecting Drug Users in High Risk Countries An Assessment of The Evidence., Institute of Medicine, National Academies of Sciences, USA
    01 Sep 2005 - 01 Sep 2005 (International)
  • Antibiotics Prescribing Practices of Upper Respiratory Tract Infections in Primary Care, MOSTI
    01 Dec 2003 - 01 Dec 2003 (National)
  • Asean Workshop for The Exchange of Experience On Increasing Access to Treatment and Care for Plwha, APCASO
    01 Nov 2002 - 01 Nov 2002 (International)
  • Asean Workshop for The Exchange of Information On Increasing Access to Hiv/Aids Drug, ASEAN
    01 Nov 2002 - 01 Nov 2002 (International)
  • Asean Workshop for The Exchange of Information On Increasing Access to Hiv/Aids Drug, APCASO
    01 Nov 2002 - 01 Nov 2002 (International)
  • Visiting Consultant Physician, Institut Jantung Negara
    01 Sep 2000 - 01 Sep 2002 (National)
  • Asean Forum On Hiv/Aids. Port Dickson., Ministry of Health Malaysia
    01 Nov 2001 - 01 Nov 2001 (National)
  • United Nations General Assembly Special Session On Hiv/Aids, United Nations
    01 Nov 2001 - 01 Nov 2001 (International)
  • UK Department for International Development Hiv-Aids Project. Towards a Strategy for Commonwealth Universities Geneva., Association of Commonwealth Universities
    01 Nov 2001 - 01 Nov 2001 (International)
  • Special Session On Hiv/Aids. New York., United Nations General Assembly
    01 Nov 2001 - 01 Nov 2001 (International)
  • Who Global Strategy for Containment of Antimicrobial Resistance Geneva., World Health Organisation
    01 Nov 2000 - 01 Nov 2000 (International)
  • Workshop On Notifiable Diseases., Ministry of Health Malaysia
    01 Nov 2000 - 01 Nov 2000 (National)

PAPER PRESENTED

PLENARY SPEAKER
  1. Substance Abuse and Harm Reduction, XVII International AIDS Conference August 2008. Mexico City. (International) (01 Aug 2008)
INVITED SEMINAR
  1. , Seminar on Rights and Responsibilities of Government Doctors, SCHOMOS / MOH (National) (03 Nov 2012 - 03 Nov 2012)
  2. , The First ASEANS Deans' Summit : Connecting ASEAN Medical Schools towards One Community" - International Conference in Medicine and Public Health (ICMPH) 2012, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand (International) (17 Sep 2012 - 17 Sep 2012)
INVITED SPEAKER
  1. Population Approach to HIV Prevention & Control, The 5th AHLA International Health Literacy Conference, Centre for Population Health (CePH), Dept of Social and Preventive Medicine, Faculty of Medicine, UM (National) (12 Nov 2017 - 14 Nov 2017)
  2. Malaysian Society for Molecular Biology and Biotechnology, 22nd Annual MSMBB Scientific Meeting, Malaysian Society for Molecular Biology and Biotechnology (National) (08 Sep 2015 - 09 Sep 2015)
  3. Towards A Unified Approach to Patient Safety : The ASEAN Perspective, 1st ASEAN Patient Safety Congress, UP College of Medicine (25 Jun 2015 - 26 Jun 2015)
  4. , 7th National Infectious Diseases Seminar and Workshop (NIDSAW)2012, Universiti Putra Malaysia (National) (06 Nov 2013 - 06 Nov 2013)
  5. Accreditation on Medical School, Summit on Medical Education 2013, University Teknologi MARA (National) (23 Aug 2013 - 23 Aug 2013)
  6. International Collaboration & Getting to Zero, 26th Annual Japan HIV Conference , Japanese Society for AIDS Research (International) (24 Nov 2012 - 26 Nov 2012)
  7. Viral Hepatitis and HIV Coinfection, Singapore AIDS COnference, Singapore AIDS Conference (International) (17 Nov 2012 - 17 Nov 2012)
  8. AIDS in Asia at the symposia on HIV , 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID) , 13th Asia-Pacific Congress of Clinical Microbiology and Infection (13th APCCMI, formerly WPCCID)  (International) (25 Oct 2012 - 28 Oct 2012)
  9. HIV and Mobility, Asia Pacific Conference in Medical Virology 2012 , APCMV 2012 Congress (International) (06 Jun 2012 - 08 Jun 2012)
  10. HIV care under universal coverage:challenges and choices, Global Public Health International Symposium on "Universal Coverage", Monash University (International) (03 Oct 2011 - 01 Oct 2011)
  11. HIV and AIDS in Muslim Countries, Women In Science and Technology in Muslim Countries , MOSTI (National) (21 Sep 2011)
  12. , 5th National Conference for Clinical Research 2011, Ministry of Health Malaysia (National) (22 Jun 2011 - 24 Jun 2011)
  13. HIV Prevention in Malaysia, Global Health Centre, Columbia University, Almaty, Kazakshtan. May 2010. HIV Prevention in Malaysia, Columbia University (International) (31 May 2010 - 31 May 2010)
  14. Monash University Malaysia Graduation Address, Monash University Malaysia Graduation Address, Monash University  (International) (10 Apr 2010 - 10 Apr 2010)
  15. Carbapenem-resistant Pseudomonas and Acinetobacter, 13th International Congress in Infectious Diseases (ICID). Kuala Lumpur, International Society of Infectious Diseases (International) (23 Jun 2008)
PRESENTER
  1. Two decades of harm reduction in Malaysia, The 27th IFNGO World Conference, IFNGO - International Federation of Non - Government Organizations for the Prevention of Drug and Substance Abuse (International) (06 Nov 2017 - 08 Nov 2017)
  2. , Islam and HIV/AIDS International Conference 2012, Department of Islamic Development Malaysia (National) (19 Nov 2013 - 21 Nov 2013)
OTHERS
  1. , MMA SECOND SEMINAR ON POSTGRADUATE MEDICAL EDUCATION, Malaysian Medical Association (National) (26 Jan 2013 - 26 Jan 2013)
  2. Substance Abuse and Harm Reduction in Malaysia, XV111 International AIDS Conference July 2010. Vienna. Substance Abuse and Harm Reduction in Malaysia, International AIDS Society (International) (17 Jul 2010 - 24 Jul 2010)
  3. Respondent Driven Sampling Involving the Community, XV111 International AIDS Conference July 2010. Vienna. Respondent Driven Sampling Involving the Community, International AIDS Society (International) (17 Jul 2010 - 24 Jul 2010)
  4. Scalling up Harm Reduction in Malaysia, XIII th International Congress of AIDS in Asia and the Pacific (ICAAP)Aug 2009, AIDS Soceity Asia Pacific (International) (01 Aug 2009)
  5. International Experience of Harm Reduction, Xth International Conference of Drug Dependence. Xian, China. October 2008, The Chinese Society of Addiction Medicine  (International) (01 Oct 2008)

ACADEMIC/PROF. SERVICES

Contribution to external organisation
  1. (2018) Member, National Health Advisory Committee, Ministry of Health Malaysia
  2. (2017) Board of Director , Clinical Research Malaysia
  3. (2016) Scientific Exchange Program , Global Health Equity Scholars - Yale university , International
  4. (2014) PhD Selection Committee Pasteur-Paris Institute, Pasteur Institute, Paris , International
  5. (2013) Student Exchange Program , Yale university , International
  6. (2011) Board Member , UMMC
  7. (2011) Board Member , UMSC
  8. (2010) Co-chairperson, Scientific Program Committee International AIDS Conference, Vienna 2010, International AIDS Society , International
  9. (2009) Country Coordinating Mechanism , The Malaysian Global Fund, Country Coordinating Mechanism , The Malaysian Global Fund
  10. (2008) Member, Oversight Committee for the Second Independent Evaluation of UNAIDS, UNAIDS, International
  11. (2008) Executive Committee Member, International Society for Infectious Diseases (ISID), International
  12. (2007) Member, United Nations Reference Group on HIV and Injecting Drug Use, United Nations , International
  13. (2006) Advisory Board Member, UNAIDS Interagency Reference Group for the Technical Support Facility in Southeast Asia and the Pacific, UNAIDS, International
  14. (2006) Member, United Nations Regional Task Force on HIV Prevention in Injecting Drug Users, United Nations, International
  15. (2006) Advisory Board Member, International Harm Reduction Development, International Harm Reduction Development, International
  16. (2006) Vice-Chair, Global Initiatives Committee- Foundation for AIDS Research (amfAR), amfAR, International
  17. (2006) Executive Committee Member, International Harm Reduction Association, International Harm Reduction Association, International
  18. (2006) Chairman , Malaysian AIDS Foundation
  19. (2006) Board Member , Malaysian AIDS Council
  20. (2005) Steering Committee Member, Asian Network on Surveillance of Resistant Pathogens (ANSORP), ANSORP, International
  21. (2005) Steering Committee Member. TREAT Asia. Regional Cooperative Network on Research and Therapeutics in HIV/AIDS. American Foundation for AIDS Research (amfAR), amfAR, International
  22. (2005) Member, Technical Expert Panel - UNAIDS Regional Task Force on IDU, consultative meeting, UNAIDS, International
  23. (2001) Member, Expert Panel - National Consensus Guidelines for the Management of Extended-spectrum Beta-Lactamase Producing Bacteria, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, National
  24. (2001) Co-Chairperson - Consensus meeting on the use of antiretroviral therapy in Malaysia, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, National
  25. (1999) Chairperson - Consensus Guidelines on the management of Staphylococcus aureus infections, Academy of Medicine M'sia/M'sian Society for Infectious Diseases & Chemotheraphy, National
  26. (1998) Member, Expert Panel - Consensus on the use of antiretroviral therapy in emerging nations, BMS, International
Contribution to event
  1. (2022) Chevening Alumni Malaysia (Cam) - Speaker, National, (Panelist/Moderator)
  2. (2022) Manipal Academy of Higher Education (Mahe), Dubai Campus, National, (Panelist/Moderator)
  3. (2021) Hiv Conference/Workshop, International, (Panelist/Moderator)
  4. (2021) National Taiwan University Cancer Center, The International Conference Room, International, (Panelist/Moderator)
  5. (2021) Outright Action International, International, (Panelist/Moderator)
  6. (2021) Chevening Alumni Malaysia (Cam), National, (Panelist/Moderator)
  7. (2021) Manipal Academy of Higher Education (Mahe), Dubai Campus, National, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2009) PhD, Yong Yean Kong
  2. (2009) PhD, Tan Hong Yien
  3. (2009) PhD, Dr Salwa Mudddthir Ismail Norien
  4. (2008) PhD, Tee Kok Keng
Master
  1. (2009) MSC, Tunku Noor Hayati Binti Tunku Abdul Rahman
  2. (2009) MSC, Martin Choo
  3. (2008) MMed, Dr Sufian Adnan
  4. (2008) MMed, Dr Azureen Azmel
  5. (2008) ADVANCED TRAINING IN INFECTIOUS DISEASES, Dr Leong Chee Loong
  6. (2008) ADVANCED TRAINING IN INFECTIOUS DISEASES, Dr James Koh
  7. (2007) MMed, Dr Sufian Adnan
  8. (2006) MMed, Dr Sufian Adnan
  9. (2004) MMed, Dr Wong Chew Ming
  10. (2004) MMed, Dr Muhammad Zainafyah Bin Zakaria

SOCIAL RESPONSIBILITY ACTIVITIES

  • Malaysian Aids Foundation Board of Trustees, (14 May 2018 - 13 May 2020)
  • Speciality Subcommittee Infectious Disease - Committee Member, (04 Jan 2016 - 03 Jan 2018)
  • Angggota Majlis Penasihat Program Jelajah Kaseh Orang Muda Okb Derma Organ Demi Kehidupan, (24 Jul 2015)
  • Perlantikan Sebagai External Reviewer Bagi Garis Panduan Antibiotik Kebangsaan 2014, (17 Dec 2014)
  • 20th International Aids Conference Melbourne, Australia - Editors Reviewers, (20 Jul 2014 - 25 Jul 2014)
  • Ahli Majlis Perubatan Malaysia, (22 Dec 2013 - 21 Dec 2016)
  • Ahli Panel Pakar Bidang Perubatan dan Sains Kesihatan, (19 Feb 2013 - 18 Feb 2015)
  • Subspeciality Training Subcommittee, (28 Sep 2012 - 27 Sep 2014)
  • National Specialist Register, (20 Jun 2012)
  • Panel Penilai Pakar Untuk Penilaian Permohonan Pembiayaan dan Pemantauan Dana R, D&C Kementerian Sains, Teknologi dan Inovasi (Mosti), (01 Mar 2012 - 31 Dec 2015)
  • Executive Committee, Malaysian Aids Council, (01 Jan 2010 - 31 Dec 2016)
  • Vice-Chair, Country Coordinating Mechanism, The Malaysian Global Fund Initiative ., (01 Jan 2009 - 31 Jul 2009)
  • Member, National Health Promotions Board, (01 Jan 2008 - 01 Apr 2010)
  • Malaysian Aids Foundation - Chairman, (01 Jan 2006 - 31 Dec 2016)
  • President Malaysian Aids Council, (01 Jan 2006 - 01 Apr 2010)
  • Member, National Task Force On Harm Reduction, Ministry of Health Malaysia, (01 Jan 2005)
  • Member, National Infection Control and Antibiotic Committee, Ministry of Health, (01 Jan 2005)
  • Convenor, Malaysian Harm Reduction Working Group, (01 Jan 2004)